146 related articles for article (PubMed ID: 7571921)
1. [Therapeutic drug monitoring and the pharmacokinetics of carbamazepine in children with a convulsive syndrome].
Kholodov LE; Prityko AG; Ivanova ES; Sokolov AV; Tishchenkova IF; Dubrovina LIu; Postnikov SS; Tatarinov PA; Kopanev IuA; Veselov NK
Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(3):35-40. PubMed ID: 7571921
[TBL] [Abstract][Full Text] [Related]
2. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
4. Effect of vigabatrin on the pharmacokinetics of carbamazepine.
Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I; Llopis P
J Clin Pharm Ther; 2002 Dec; 27(6):427-30. PubMed ID: 12472982
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.
Bondareva IB; Jelliffe RW; Gusev EI; Guekht AB; Melikyan EG; Belousov YB
J Clin Pharm Ther; 2006 Jun; 31(3):211-21. PubMed ID: 16789986
[TBL] [Abstract][Full Text] [Related]
6. Influence of caffeine on pharmacokinetic profile of sodium valproate and carbamazepine in normal human volunteers.
Vaz J; Kulkarni C; David J; Joseph T
Indian J Exp Biol; 1998 Jan; 36(1):112-4. PubMed ID: 9536660
[TBL] [Abstract][Full Text] [Related]
7. Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.
Marino SE; Birnbaum AK; Leppik IE; Conway JM; Musib LC; Brundage RC; Ramsay RE; Pennell PB; White JR; Gross CR; Rarick JO; Mishra U; Cloyd JC
Clin Pharmacol Ther; 2012 Mar; 91(3):483-8. PubMed ID: 22278332
[TBL] [Abstract][Full Text] [Related]
8. Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication.
Kong ST; Lim SH; Chan E; Ho PC
J Clin Pharmacol; 2014 Feb; 54(2):225-33. PubMed ID: 23996245
[TBL] [Abstract][Full Text] [Related]
9. Association of drug levels & pharmacokinetics of carbamazepine with seizure control.
Vasudev A; Tripathi KD; Puri V
Indian J Med Res; 2000 Dec; 112():218-23. PubMed ID: 11247200
[TBL] [Abstract][Full Text] [Related]
10. Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy.
Rey E; Bulteau C; Motte J; Tran A; Sturm Y; D'Souza J; Markabi S; Pons G; Dulac O
J Clin Pharmacol; 2004 Nov; 44(11):1290-300. PubMed ID: 15496647
[TBL] [Abstract][Full Text] [Related]
11. [Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy].
Avakian GN; Oleĭnikova OM; Lagutin IuV; Khromykh EA; Bogomazova MA; Delger AB; Avakian GG
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(11):34-9. PubMed ID: 24429946
[TBL] [Abstract][Full Text] [Related]
12. [Role of the pharmacokinetic parameters of carbamazepine in optimizing epilepsy treatment].
Okudzhava VM; Antadze ZI; Chankvetadze BG; Vetrogon FG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1327-9. PubMed ID: 3425074
[TBL] [Abstract][Full Text] [Related]
13. Carbamazepine drug interactions: the influence of concurrent drug therapy on serum concentrations of carbamazepine and its epoxide metabolite.
Wang RB; Liu LT; Yiu CH; Chang TY
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Apr; 45(4):222-32. PubMed ID: 2168269
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
[TBL] [Abstract][Full Text] [Related]
15. Phenobarbital pharmacokinetics in old age: a case-matched evaluation based on therapeutic drug monitoring data.
Messina S; Battino D; Croci D; Mamoli D; Ratti S; Perucca E
Epilepsia; 2005 Mar; 46(3):372-7. PubMed ID: 15730534
[TBL] [Abstract][Full Text] [Related]
16. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
17. Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin.
Gustavson LE; Cato A; Boellner SW; Cao GX; Qian JX; Guenther HJ; Sommerville KW
Am J Ther; 1998 Jan; 5(1):9-16. PubMed ID: 10099032
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment and additional disease on pharmacokinetic of valproic acid in children with epilepsy.
Juárez-Olguín H; Lugo-Goytia G; Flores-Murrieta F; Ruiz-García M; Lares Asseff I; Flores Pérez J
Rev Invest Clin; 2010; 62(6):516-23. PubMed ID: 21416779
[TBL] [Abstract][Full Text] [Related]
19. [Carbamazepine dosage and its blood serum level in children].
Czochańska J; Losiowski Z; Prokopczyk J; Zimak J
Neurol Neurochir Pol; 1987; 21(1):6-10. PubMed ID: 3614524
[TBL] [Abstract][Full Text] [Related]
20. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
Otoul C; De Smedt H; Stockis A
Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
